Home/Federal Circuit/Novartis Pharmaceuticals Corp. v. Mylan Pharmaceuticals Inc.

Novartis Pharmaceuticals Corp. v. Mylan Pharmaceuticals Inc.

440 F. App'x 924
Court of Appeals for the Federal Circuit·Decided December 6, 2011·No. No. 2011-1203·Published

Opinion

[925] ON MOTION

ORDER

Mylan Pharmaceuticals Inc. and Mylan Inc. move to dismiss their appeal.

Upon consideration thereof,

It Is Ordered That:

(1) The motion is granted. The appeal is dismissed.

(2) Each side shall bear its own costs.

Free access — add to your briefcase to read the full text and ask questions with AI

Novartis Pharmaceuticals Corp. v. Mylan Pharmaceuticals Inc., 440 F. App'x 924 (Fed. Cir. 2011).

440 F. App'x 924 (Novartis Pharmaceuticals Corp. v. Mylan Pharmaceuticals Inc.) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.